LivaNova PLC - Ordinary Shares (LIVN) News

LivaNova PLC - Ordinary Shares (LIVN): $81.79

0.57 (+0.70%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter LIVN News Items

LIVN News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

LIVN News Highlights

  • 500 - Internal server error
  • Over the past 15 days, the trend for LIVN's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • The most mentioned tickers in articles about LIVN are CSL and HAE.

Latest LIVN News From Around the Web

Below are the latest news stories about LivaNova PLC that investors may wish to consider to help them evaluate LIVN as an investment opportunity.

Helius Medical Technologies, Inc. Appoints Frederick Fantazzia as Vice President of Sales & Marketing, North America

NEWTOWN, Pa., June 02, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced the appointment of Frederick Fantazzia to the position of Vice President of Sales & Marketing, North America, effective June 1, 2021. “Fred is a dynamic leader with 16 years of sales and marketing experience in the field of neuromodulation, and a specific focus on developing the market for new

Yahoo | June 2, 2021

LivaNova Completes Initial Closing of Heart Valve Business to Gyrus Capital

LivaNova PLC today announced it has successfully completed the initial closing of the divestiture of its heart valve business to Gyrus Capital.

Yahoo | June 1, 2021

Haemonetics Corp: Contrarian Flavour With Recent Market Punishment

Photo by Elkhophoto/iStock via Getty ImagesInvestment Summary Back in April, Haemonetics Corp (HAE) revealed their supply agreement with CSL Plasma, covering the use of PCS2, will not continue for the from 06/30/2022. As of FY2020, total revenues were exposed ~12% to this high-margin agreement, therefore, ~12% of HAE's top line...

Zach Bristow on Seeking Alpha | May 18, 2021

When Will LivaNova PLC (NASDAQ:LIVN) Turn A Profit?

LivaNova PLC ( NASDAQ:LIVN ) is possibly approaching a major achievement in its business, so we would like to shine...

Yahoo | May 3, 2021

LivaNova and Verily Announce First Patient Enrolled in Study to Evaluate Treatment Effectiveness for Patients Living with Depression

LivaNova and Verily today announced that the first patient has been enrolled in their collaborative UNCOVER study for difficult-to-treat depression.

Yahoo | April 26, 2021

LivaNova Receives FDA 510(k) Clearance for B-Capta, the New In-Line, Blood-Gas Monitoring System Integrated Into the S5 Heart-Lung Machine

LivaNova today announced it received U.S. FDA 510(k) clearance for B-Capta, the new in-line, blood-gas monitoring system integrated into the S5 HLM.

Yahoo | April 20, 2021

Epilepsy Market Undertake Strapping Growth By 2027 With LivaNova PLC, GlaxoSmithKline PLC, Eisai Co. Ltd., Pfizer Inc., Medtronic PLC, GW Pharmaceuticals PLC, Novartis AG, Johnson & Johnson Services Inc., Abbott Laboratories, Becton Dickinson and Company

Epilepsy research report provides deep insights into the Global Epilepsy market revenue, parent market trends, macro-economic indicators, and governing factors, along with market attractiveness per market segment. The report provides an overview of the growth rate of the Epilepsy during

OpenPR | March 22, 2021

Cardiopulmonary Autotransfusion Systems Market is Thriving Worldwide 2021-2025 | Leading Players - Medtronic, Terumo, Advancis Surgical, Fresenius Kabi, Haemonetics, LivaNova, Stryker

BusinessIndustryReports has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Cardiopulmonary Autotransfusion Systems Market” Research Report 2021 provides an in-depth analysis of the Cardiopulmonary Autotransfusion Systems with the forecast of market size and

OpenPR | March 17, 2021

Active Implantable Medical Devices Market 2021 - 2027 Size, Industry Share, Growth, COVID-19 Analysis, Top Key Players : Boston Scientific Corporation, Biotronik, LivaNova PLC, Globus Medical, Inc., NuVasive

Rise in prevalence of chronic diseases, supportive initiatives from medical health insurance companies for critical issues, and increase in awareness regarding different types of implants drive the growth of the global medical implant market. However, high cost of treatment and

OpenPR | March 16, 2021

Autotransfusion Device Market With Leading Players like Medtronic, Fresenius SE & Co. KGaA, Teleflex Incorporated BD, Zimmer Biomet, BraileBiomedica, Haemonetics Corporation, SARSTEDT AG and Co. KG, LivaNova PLC, Redax S.p.A.

An off-the-shelf report on Autotransfusion Device Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments of the market such as

OpenPR | March 15, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5932 seconds.